Female-led stocks: Who rules the world?
34 No. of Symbols
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
30.63 MXN
104.05 B MXN
640.33 B MXN
2.04 B
About GSK PLC ORD GBP0.3125
GSK Plc is a healthcare company, which engages in the research, development, and manufacture of pharmaceutical medicines, vaccines, and consumer healthcare products. It operates through the Commercial Operations, and Research and Development segments. The Commercial Operations segment has three product groups of specialty medicines, vaccines, and general medicines. The company was founded in 1715 and is headquartered in Middlesex, the United Kingdom.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
G
17RI
GLAXOSMITHKLINE CAPITAL PLC 4.25% GTD SNR EMTN 18/12/45Yield to maturity
6.06%
Maturity date
Dec 18, 2045
G
GSK3981911
GlaxoSmithKline Capital, Inc. 4.2% 18-MAR-2043Yield to maturity
5.42%
Maturity date
Mar 18, 2043
G
83GI
GLAXOSMITHKLINE CAPITAL PLC 5.25% GTD SNR EMTN 10/04/2042Yield to maturity
5.21%
Maturity date
Apr 10, 2042
G
GSK.GJ
GlaxoSmithKline Capital, Inc. 6.375% 15-MAY-2038Yield to maturity
4.92%
Maturity date
May 15, 2038
G
71ZC
GLAXOSMITHKLINE CAPITAL PLC 6.375% GTD SNR EMTN 09/03/39Yield to maturity
4.85%
Maturity date
Mar 9, 2039
G
GSK4632357
GlaxoSmithKline Capital, Inc. 3.625% 15-MAY-2025Yield to maturity
4.61%
Maturity date
May 15, 2025
G
72WI
GLAXOSMITHKLINE CAPITAL INC 5.375% GTD SNR NTS 15/04/2034Yield to maturity
4.58%
Maturity date
Apr 15, 2034
Explore more bonds
Curated watchlists where GSK/N is featured.
Frequently Asked Questions
The current price of GSK/N is 739.40 MXN — it has decreased by −0.08% in the past 24 hours. Watch GSK PLC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on BMV exchange GSK PLC stocks are traded under the ticker GSK/N.
GSK/N stock has risen by 11.02% compared to the previous week, the month change is a −4.63% fall, over the last year GSK PLC has showed a 17.35% increase.
We've gathered analysts' opinions on GSK PLC future price: according to them, GSK/N price has a max estimate of 1,282.95 MXN and a min estimate of 607.24 MXN. Watch GSK/N chart and read a more detailed GSK PLC stock forecast: see what analysts think of GSK PLC and suggest that you do with its stocks.
GSK/N reached its all-time high on Apr 29, 2020 with the price of 1,327.50 MXN, and its all-time low was 494.21 MXN and was reached on Apr 14, 2009. View more price dynamics on GSK/N chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
GSK/N stock is 0.08% volatile and has beta coefficient of 0.31. Track GSK PLC stock price on the chart and check out the list of the most volatile stocks — is GSK PLC there?
Today GSK PLC has the market capitalization of 1.42 T, it has increased by 0.25% over the last week.
Yes, you can track GSK PLC financials in yearly and quarterly reports right on TradingView.
GSK PLC is going to release the next earnings report on Feb 5, 2025. Keep track of upcoming events with our Earnings Calendar.
GSK/N earnings for the last quarter are 25.48 MXN per share, whereas the estimation was 22.70 MXN resulting in a 12.25% surprise. The estimated earnings for the next quarter are 10.39 MXN per share. See more details about GSK PLC earnings.
GSK PLC revenue for the last quarter amounts to 205.38 B MXN, despite the estimated figure of 207.22 B MXN. In the next quarter, revenue is expected to reach 202.00 B MXN.
GSK/N net income for the last quarter is −1.49 B MXN, while the quarter before that showed 27.15 B MXN of net income which accounts for −105.47% change. Track more GSK PLC financial stats to get the full picture.
GSK PLC dividend yield was 3.87% in 2023, and payout ratio reached 47.48%. The year before the numbers were 3.88% and 14.90% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Dec 4, 2024, the company has 70.21 K employees. See our rating of the largest employees — is GSK PLC on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. GSK PLC EBITDA is 225.64 B MXN, and current EBITDA margin is 30.62%. See more stats in GSK PLC financial statements.
Like other stocks, GSK/N shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade GSK PLC stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So GSK PLC technincal analysis shows the buy rating today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating GSK PLC stock shows the sell signal. See more of GSK PLC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.